BioNTech receives $250m investment amid vaccine development
June sees BioNTech secure hundreds of millions in investment to progress pipeline, including mRNA COVID-19 vaccine.
Archives for June 30, 2020
CSL Behring in $450m spend on hemophilia gene therapy
The company buys the global rights to a gene therapy currently going through Phase III trials.
Inovio posts positive COVID-19 vaccine results but few details
The biotech reveals positive results of Phase I trials but does not provide a fuller picture of data.